Drug intelligence / Profile preview

lunasin-enriched soy extract

Development stage
Preclinical
Lead developer
Missouri Plant Science Center
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Oral
01

Overview

Lunasin-enriched soy extract is a dietary supplement derived from soybeans and specifically enriched for the bioactive peptide lunasin. Lunasin is a 43–44 amino acid peptide with an intramolecular disulfide bond, naturally present in soy and some other grains. The extract contains significantly higher concentrations of lunasin compared to standard soy protein isolates[4][9]. Mechanistically, lunasin exhibits antioxidant, anti-inflammatory, hypocholesterolemic (cholesterol-lowering), and anticancer properties. It acts epigenetically by binding to histone H3 and inhibiting its acetylation by PCAF histone acetylase enzyme; this downregulates HMG-CoA reductase expression (the rate-limiting enzyme in cholesterol biosynthesis) and upregulates LDL receptor expression in liver cells[4]. Lunasin also reduces reactive oxygen species (ROS) production and pro-inflammatory cytokines such as interleukin-1β and interleukin-8[1][5][9]. In cancer models, it inhibits cell proliferation via disruption of mitotic spindle formation and modulates integrin-mediated cell adhesion pathways[7][8]. The product is typically administered orally as capsules or powders but can be formulated into various oral dosage forms[3].

Other names
LSElunasin-enriched soybean extractLES
02

Targets

H3/H4 (Histone H3-H4 complex)KAT2BH3 (Histone H3.2)

Beyond the preview

Go deeper on lunasin-enriched soy extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lunasin-enriched soy extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call